Literature DB >> 4188269

Disposal of plasma heme in normal man and patients with intravascular hemolysis.

D A Sears.   

Abstract

The clearance of plasma protein-bound heme, its sites of removal, and the reutilization of hemeiron were studied by radioisotopic techniques in normal human subjects and in patients with intravascular hemolysis. In normal subjects, injected heme-(59)Fe was bound immediately by albumin and the beta(1)-globulin, hemopexin. Its clearance from the plasma was descr bed by a single exponential equation, and the half-life in plasma was 7-8 hr. Removal was largely by the liver. Iron reutilization began promptly, and half the injected heme-iron was incorporated into circulating red cells within one cell life-span. In patients with intravascular hemolysis, hemopexin was depleted, and injected heme was bound solely to albumin. Plasma clearance was described by a double exponential equation of the form: y = Ae(-k1t) + Be(-k2t). The half-lives of the two components averaged 3.9 and 22.2 hr, respectively. Removal was by the liver in at least some of the patients, and iron reutilization was variable, depending on the state of body iron stores. When hemopex'n was depleted in a normal subject by repeated heme injection, clearance mimicked that observed in the patients.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4188269      PMCID: PMC322438          DOI: 10.1172/JCI106222

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Plasma heme-binding in patients with hemolytic disorders.

Authors:  D A Sears
Journal:  J Lab Clin Med       Date:  1968-03

2.  Exchange of heme among hemoglobins and between hemoglobin and albumin.

Authors:  H F Bunn; J H Jandl
Journal:  J Biol Chem       Date:  1968-02-10       Impact factor: 5.157

3.  Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases.

Authors:  U Muller-Eberhard; J Javid; H H Liem; A Hanstein; M Hanna
Journal:  Blood       Date:  1968-11       Impact factor: 22.113

4.  Studies on the disposal of intravascular heme in the rabbit.

Authors:  U Muller-Eberhard; H H Liem; A Hanstein; P A Saarinen
Journal:  J Lab Clin Med       Date:  1969-02

5.  The sites of hemoglobin catabolism.

Authors:  W R Keene; J H Jandl
Journal:  Blood       Date:  1965-12       Impact factor: 22.113

6.  Plasma hematin-binding and clearance in the rhesus monkey.

Authors:  D A Sears; H J Huser
Journal:  Proc Soc Exp Biol Med       Date:  1966-01

7.  Mechanisms of plasma hemoglobin clearance after acute hemolysis: studies in open-heart surgical patients.

Authors:  M N Andersen; C V Mouritzen; E Gabrieli
Journal:  Ann Surg       Date:  1966-04       Impact factor: 12.969

8.  Blood ferrokinetics in normal man.

Authors:  F Hosain; G Marsaglia; C A Finch
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

9.  Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases.

Authors:  D A Sears; P R Anderson; A L Foy; H L Williams; W H Crosby
Journal:  Blood       Date:  1966-11       Impact factor: 22.113

10.  Evaluation of a stroma-free hemoglobin solution for use as a plasma expander.

Authors:  S F Rabiner; J R Helbert; H Lopas; L H Friedman
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

View more
  10 in total

1.  Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease.

Authors:  Grace Chen; Dachuan Zhang; Tobias A Fuchs; Deepa Manwani; Denisa D Wagner; Paul S Frenette
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

2.  [Properties, function and serum concentration of human hemopexin].

Authors:  H J Braun
Journal:  Klin Wochenschr       Date:  1971-04-15

3.  Myocyte injury by hemin.

Authors:  V Bhoite-Solomon; G Kessler-Icekson; N Shaklai
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-08       Impact factor: 2.416

4.  Heme interacts with c1q and inhibits the classical complement pathway.

Authors:  Lubka T Roumenina; Maria Radanova; Boris P Atanasov; Krastio T Popov; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Véronique Frémeaux-Bacchi; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

5.  Apohemoglobin-haptoglobin complex attenuates the pathobiology of circulating acellular hemoglobin and heme.

Authors:  Carlos J Munoz; Ivan S Pires; Jin Hyen Baek; Paul W Buehler; Andre F Palmer; Pedro Cabrales
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-04-17       Impact factor: 4.733

6.  Iron Supplementation Alters Heme and Heme Oxygenase 1 (HO-1) Levels In Pregnant Women in Ghana.

Authors:  Hassana Salifu; Nana O Wilson; Mingli Liu; Carmen Dickinson-Copeland; Nelly Yatich; John Keenan; Cornelius Turpin; Pauline Jolly; Richard Gyasi; Andrew A Adjei; Jonathan K Stiles
Journal:  SOJ Microbiol Infect Dis       Date:  2016-09-14

7.  Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein.

Authors:  A Smith; W T Morgan
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

8.  Novel heme-binding component in the serum of the channel catfish (Ictalurus punctatus).

Authors:  G Massad; J E Arceneaux; B R Byers
Journal:  Biometals       Date:  1992       Impact factor: 2.949

9.  The anticoagulant effect of Apis mellifera phospholipase A2 is inhibited by CORM-2 via a carbon monoxide-independent mechanism.

Authors:  Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

Review 10.  Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders.

Authors:  Ann Smith; Russell J McCulloh
Journal:  Front Physiol       Date:  2015-06-30       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.